OTC · ETXPF
E-therapeutics Plc
$0.13$0.00 (0.0%)
E-therapeutics Plc: Healthcare · Biotechnology.
Loading market information…
OTC · BSTG · USD
Stock price, earnings
Quote as of Jul 19, 2023, 07:14 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Biostage, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Biostage, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.13$0.00 (0.0%)
E-therapeutics Plc: Healthcare · Biotechnology.
$0.26$0.00 (0.0%)
Karolinska Development AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 58.0% below the high.
SEK 1.67-SEK 0.04 (-2.22%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.75% below the high.
$0.45$0.00 (0.0%)
Goodness Growth Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.54-$0.00 (-0.37%)
Mindset Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
$0.55-$0.01 (-1.1%)
MCI Onehealth Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.47% below the high.
$0.82$0.00 (0.0%)
Medivir AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.89% below the high.
$0.03$0.00 (0.0%)
Abliva AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 25.13% below the high.
